TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

9 Months Ended

Sep. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Note 6 - Intangible Assets

Intangible assets as of September 30, 2014 and December 31, 2013 and the movements for the three months then ended are as follows:

			Distributor &
	Patents &		Customer
	Trademarks		Relationships		Totals
Cost or Deemed Cost
At December 31, 2013		3,851,494		1,270,639		5,122,133
Additions		-		-		-
Disposals		-		-		-
At September 30, 2014		3,851,494		1,270,639		5,122,133

Accumulated Amortization
At December 31, 2013		1,416,857		1,270,639		2,687,496
Amortization Charge		193,930		-		193,930
Disposals		-		-		-
At September 30, 2014		1,610,787		1,270,639		2,881,426

Net Book Value
At December 31, 2013		2,434,637		-		2,434,637
At September 30, 2014	$	2,240,707	$	-	$	2,240,707

Amortization expense was $64,643 and $193,930 for the three and nine months ended September 30, 2014 and $64,643 and $193,929 for the three and nine months ended September 30, 2013.